Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New CMO For Sanifit

Executive Summary

Spanish biopharma company Laboratoris Sanifit S.L. has appointed Dr Preston S. Klassen chief medical officer and president of its new US subsidiary, Sanifit Inc. Klassen joins the business from Orexigen Therapeutics, where he headed the global development team as executive vice president. He previously held various positions at Amgen Inc., including therapeutic area head for nephrology, prior to which he was a faculty member at Duke University’s division of nephrology for five years.

You may also be interested in...



Executives On The Move: New CEOs at Topas Therapeutics, Lumeda And WntResearch

Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.

Coronavirus Update: Human Vaccine Challenge Study Gains UK Backing

The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.

Executives On The Move: CEOs Named At Kaleido Biosciences, DewPoint Therapeutics And WntResearch AB

New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.

Topics

UsernamePublicRestriction

Register

LL038093

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel